Abstract | OBJECTIVE: METHODS AND RESULTS: In a 90-min ischemia and 3-h reperfusion model, minipigs were assigned into sham, ischemia-reperfusion (IR), IR+IP, IR+IP+L-NNA (an eNOS inhibitor, 10mg·kg(-1)), IR+IP+ H-89 (a PKA inhibitor, 1.0μg·kg(-1)·min(-1)), IR+L-NNA, and IR+H-89 groups. IP pretreatment improved cardiac function and coronary blood flow, decreased the activities of creatine kinase by 36.6% after 90 min of ischemia and by 32.8% after 3 h of reperfusion (P<0.05), reduced the no-reflow areas from 49.9% to 11.0% (P<0.01), and attenuated the infarct size from 78.2% to 35.4% (P<0.01). IP stimulated myocardial PKA activities and the expression of PKA and Ser(133) phosphorylated (p-) cAMP response element-binding protein (CREB) in the reflow and no-reflow myocardium, and enhanced the activities of constitutive NOS and the phosphorylation of eNOS at Ser(1179) and Ser(635) in the no-reflow myocardium. IP suppressed the expression of tumor necrosis factor-α and P-selectin, and attenuated cardiomyocytes apoptosis by regulating the expression of Bcl-2 and caspase-3 in the reflow and no-reflow myocardium. The eNOS inhibitor L-NNA completely canceled these beneficial effects of IP without any influence on PKA activity, whereas the PKA inhibitor H-89 partially blocked the IP cardioprotective effects and eNOS phosphorylation at the same time. CONCLUSION: IP attenuates myocardial no-reflow and infarction after ischemia and reperfusion by activating the phosphorylation of eNOS at Ser(1179) and Ser(635) in a partly PKA-dependent manner.
|
Authors | Xiang-Dong Li, Yu-Tong Cheng, Yue-Jin Yang, Xian-Min Meng, Jing-Lin Zhao, Hai-Tao Zhang, Yong-Jian Wu, Shi-Jie You, Yi-Ling Wu |
Journal | Microvascular research
(Microvasc Res)
Vol. 84
Issue 1
Pg. 44-54
(Jul 2012)
ISSN: 1095-9319 [Electronic] United States |
PMID | 22542438
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Nitric Oxide Synthase Type III
- Cyclic AMP-Dependent Protein Kinases
|
Topics |
- Animals
- Apoptosis
- Biomarkers
(metabolism)
- Cyclic AMP-Dependent Protein Kinases
(metabolism)
- Hemodynamics
- Ischemic Preconditioning
- Myocardial Reperfusion Injury
(metabolism, pathology, physiopathology)
- Myocardial Stunning
(metabolism, pathology, physiopathology)
- Myocardium
(enzymology, pathology)
- Nitric Oxide Synthase Type III
(metabolism)
- No-Reflow Phenomenon
(metabolism, pathology, physiopathology)
- Phosphorylation
- Swine
- Swine, Miniature
|